Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters








Database
Publication year range
1.
Sheng Wu Gong Cheng Xue Bao ; 39(9): 3849-3862, 2023 Sep 25.
Article in Chinese | MEDLINE | ID: mdl-37805859

ABSTRACT

This study was to develop a new method for detecting circulating tumor cells (CTCs) with high sensitivity and specificity, therefore to detect the colorectal cancer as early as possible for improving the detection rate of the disease. To this end, we prepared some micro-column structure microchips modified with graphite oxide-streptavidin (GO-SA) on the surface of microchips, further coupled with a broad-spectrum primary antibody (antibody1, Ab1), anti-epithelial cell adhesion molecule (anti-EpCAM) monoclonal antibody to capture CTCs. Besides, carboxylated multi-walled carbon nanotubes (MWCNTs-COOH) were coupled with colorectal cancer related antibody as specific antibody 2 (Ab2) to prepare complex. The sandwich structure consisting of Ab1-CTCs-Ab2 was constructed by the microchip for capturing CTCs. And the electrochemical workstation was used to detect and verify its high sensitivity and specificity. Results showed that the combination of immunosensor and micro-nano technology has greatly improved the detection sensitivity and specificity of the immunosensor. And we also verified the feasibility of the immunosensor for clinical blood sample detection, and successfully recognitized detection and quantization of CTCs in peripheral blood of colorectal cancer patients by this immunosensor. In conclusion, the super sandwich immunosensor based on micro-nano technology provides a new way for the detection of CTCs, which has potential application value in clinical diagnosis and real-time monitoring of disease.


Subject(s)
Biosensing Techniques , Colorectal Neoplasms , Nanotubes, Carbon , Neoplastic Cells, Circulating , Humans , Nanotubes, Carbon/chemistry , Neoplastic Cells, Circulating/pathology , Immunoassay/methods , Antibodies , Colorectal Neoplasms/diagnosis , Electrochemical Techniques/methods , Gold/chemistry
2.
Front Bioeng Biotechnol ; 10: 891727, 2022.
Article in English | MEDLINE | ID: mdl-35832403

ABSTRACT

Despite recent progress, a challenge remains on how to gently release and recover viable ctDNA captured on DNA probe-based devices. Here, a reusable detector was successfully manufactured for the capture and release of ctDNA by means of an UCNPs@SiO2-Azo/CD-probe. Biocompatible NIR light is used to excite UCNPs and convert into local UV light. Continuous irradiation induces a rapid release of the entire ctDNA-probe-CD complex from the functionalized surface via the trans-cis isomerization of azo units without disrupting the ctDNA-structure receptor. Specifically, these composite chips allow reloading DNA probes for reusable ctDNA detection with no obvious influence on their efficiency. The results of our study demonstrated the potential application of this platform for the quantitative detection of ctDNA and the individualized analysis of cancer patients.

3.
Biomed Environ Sci ; 22(3): 229-36, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19725466

ABSTRACT

OBJECTIVE: To understand the molecular basis for a potential reaction mechanism and develop novel antibiotics with homology modeling for 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) synthase (HMGS). METHODS: The genetic engineering technology and the composer module of SYBYL7.0 program were used, while the HMGS three-dimensional structure was analyzed by homology modeling. RESULTS: The mvaS gene was cloned from Streptococcus pneumoniae and overexpressed in Escherichia coli from a pET28 vector. The expressed enzyme (about 46 kDa) was purified by affinity chromatography with a specific activity of 3.24 micromol/min/mg. Optimal conditions were pH 9.75 and 10 mmol/L MgCl2 at 37 degrees C. The V(max) and K(m) were 4.69 micromol/min/mg and 213 micromol/L respectively. The 3D model of S. pneumoniae HMGS was established based on structure template of HMGS of Enterococcus faecalis. CONCLUSION: The structure of HMGS will facilitate the structure-based design of alternative drugs to cholesterol-lowering therapies or to novel antibiotics to the Gram-positive cocci, whereas the recombinant HMGS will prove useful for drug development against a different enzyme in the mevalonate pathway.


Subject(s)
Gene Expression Regulation, Bacterial/physiology , Hydroxymethylglutaryl-CoA Synthase/chemistry , Hydroxymethylglutaryl-CoA Synthase/metabolism , Streptococcus pneumoniae/enzymology , Amino Acid Sequence , Base Sequence , Cloning, Molecular , Hydroxymethylglutaryl-CoA Synthase/genetics , Models, Molecular , Molecular Sequence Data , Mutation , Protein Conformation , Streptococcus pneumoniae/genetics
SELECTION OF CITATIONS
SEARCH DETAIL